溶酶体跨膜蛋白5在卵巢癌细胞上皮-间质转化中的作用
姜晓凤1, 蔡鑫泽2, 张岩1, 魏力11. 中国医科大学附属第四医院妇科, 沈阳 110032;
2. 中国医科大学附属第一医院中心实验室, 沈阳 110001
收稿日期:
2021-12-27出版日期:
2022-08-30发布日期:
2022-07-19通讯作者:
魏力E-mail:cmu4h-wl@126.com作者简介:
姜晓凤(1989-),女,医师,硕士.基金资助:
国家自然科学基金(81401330)关键词: 卵巢癌, 溶酶体跨膜蛋白5, 上皮间质转化
Abstract: Objective To detect the expression of lysosomal protein transmembrane 5(LAPTM5) in human ovarian adenocarcinoma cells(OVCAR3), observe the effect of LAPTM5 on the migration and invasion of OVCAR3, and explore the role of LAPTM5 in epithelial-mesenchymal transformation(EMT). Methods Western blotting was used to detect LAPTM5 expression in OVCAR3. OVCAR3 cells were randomly divided into 2 groups and transfected with empty plasmids and LAPTM5 silent plasmids, respectively. Real-time quantitative polymerase chain reaction was used to measure transfection efficiency and mRNA expression levels of EMT-related markers, E-cadherin,N-cadherin, and Vimentin. Results LAPTM5 is expressed in the ovarian cancer cell line OVCAR3(P < 0.01). Compared to the control group, the migration and invasion ability of OVCAR3 cell lines transfected with LAPTM5 silenced plasmid were significantly decreased(P < 0.05), and the mRNA expression level of the EMT epithelial marker,E-cadherin, was significantly up-regulated(P < 0.05). The expression of N-cadherin mRNA and Vimentin mRNA in interstitial markers(P < 0.05) were down-regulated. Conclusion LAPTM5 is expressed in the ovarian cancer cell line OVCAR3, and LAPTM5 may affect the migration and invasion ability of OVCAR3 cells through EMT.
Key words: ovarian cancer, lysosomal protein transmembrane 5, epithelial mesenchymal transformation
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=3042